Congenital Heart Defect Devices
Feb 10, 2022
Stryker’s Tornier Shoulder Arthroplasty; Genesis Acquires JC Medical; FDA Clearance to Single-Use Gastroscope; BioCardia’s CardiAMP Cell Therapy System; Abbott’s Dual-Chamber Leadless Pacemaker; atHeart’s ASCENT ASD U.S. IDE
BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure On February 03, 2022, The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CardiAMP® Cell Therapy System for the treatment of heart failure, according to BioCardia®, ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
